Cumberland Pharma (CPIX) is scheduled to report Q2 earnings on August 4, 2026.
Cumberland Pharma has beaten EPS estimates in 2 consecutive quarters.
Over the last 2 quarters, Cumberland Pharma has averaged an EPS surprise of 0.93% and a revenue surprise of 0.09%.
Analyze the earnings history of Cumberland Pharma using advanced sorting and filters.
The chart below shows Cumberland Pharma's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Cumberland Pharma's reported revenue compared to analyst estimates over recent quarters.
Cumberland Pharma (CPIX) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
The Actual EPS was $-0.13, which missed the estimate of $0.00.
The Actual Revenue was $9.13M, which beat the estimate of $0.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2022-08-09 | $-0.01 | $-0.07 | 85.7 % |
| Q2 | 2021-08-10 | $0 | $-0.07 | 100.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2022-08-09 | $10.30M | $9.19M | 12.1 % |
| Q4 | 2022-03-08 | $8.32M | $9.19M | -9.47 % |
| Q3 | 2021-11-09 | $8.07M | $9.19M | -12.2 % |
| Q2 | 2021-08-10 | $9.06M | $8.57M | 5.66 % |